Our rationale for choosing these modules as relevant to the KRAS pathway in cancer was as follows: it has been demonstrated that MYC integrates RAS and PI3K signals and that both under- and overexpression of MYC can lead to cancer cell death [16, 17]. Here, KRAS is linked to cancer.